for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Inotiv Inc

NOTV.OQ

Latest Trade

32.36USD

Change

0.00(0.00%)

Volume

73,725

Today's Range

31.80

 - 

33.46

52 Week Range

11.21

 - 

60.61

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
32.36
Open
31.99
Volume
73,725
3M AVG Volume
4.20
Today's High
33.46
Today's Low
31.80
52 Week High
60.61
52 Week Low
11.21
Shares Out (MIL)
24.27
Market Cap (MIL)
797.38
Forward P/E
32.37
Dividend (Yield %)
--

Next Event

Q1 2022 Inotiv Inc Earnings Release

Latest Developments

More

Inotiv Announces Q4 EPS Of $0.06

Inotiv Announces Closing Of $125 Million Convertible Senior Notes Offering And Full Exercise Of Option To Purchase Additional $15 Million Of Notes

Inotiv Inc Prices Upsized $125 Mln Convertible Senior Notes Offering

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Inotiv Inc

Inotiv, Inc. is an international contract research company that is focused on providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates through two segments, including Contract Research Services and Research Products. The Contract Research Services segment provides screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance and quality control testing. The Research Products segment offers two principal product lines, including analytical products and in vivo sampling products. Analytical products consist of liquid chromatographic and electrochemical instruments with associated accessories. In vivo sampling products consist of the Culex family of automated in vivo sampling and dosing instruments.

Industry

Biotechnology & Drugs

Contact Info

2701 Kent Ave

WEST LAFAYETTE, IN

47906-1350

United States

+1.317.4634527

https://www.inotivco.com/

Executive Leadership

Gregory Cole Davis

Independent Chairman of the Board

Robert W. Leasure

President, Chief Executive Officer, Director

Beth A. Taylor

Chief Financial Officer, Vice President - Finance

John Gregory Beattie

Chief Operating Officer

James Harkness

Chief Operating Officer - Research Models & Services

Key Stats

1.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2020

0.1K

2021

0.1K

2022(E)

0.4K
EPS (USD)

2021

-0.520

2022(E)

1.030
Price To Earnings (TTM)
38.93
Price To Sales (TTM)
8.90
Price To Book (MRQ)
4.98
Price To Cash Flow (TTM)
36.20
Total Debt To Equity (MRQ)
157.60
LT Debt To Equity (MRQ)
146.72
Return on Investment (TTM)
10.62
Return on Equity (TTM)
8.22

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up